Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1

Journal of Hepatology

Volumn 40, Issue 3, 2004, Pages 375-379

  Yang, Xuesong ^a   Cullen, Susan N ^a   Li, Jin H ^a   Chapman, Roger W ^b   Jewell, Derek P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Intercellular adhesion molecule 1; PCR with sequence specific primer; Primary sclerosing cholangitis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ALLELE; ARTICLE; BILE DUCT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENTERITIS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 1242269880     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.11.009     Document Type: Article

References (29)

1. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
2. Smits H.H., de Jong E.C., Schuitemaker J.H., Geijtenbeek T.B., van Kooyk Y., Kapsenberg M.L., Wierenga E.A. Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development. J Immunol. 168:2002;1710-1716.
3. Wawryk S.O., Cockerill P.N., Wicks I.P., Boyd A.W. Isolation and characterization of the promoter region of the human intercellular adhesion molecule-1 gene. Int Immunol. 3:1991;83-93.
4. Mycko M.P., Kwinkowski M., Tronczynska E., Szymanska B., Selmaj K.W. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol. 44:1998;70-75.
5. Yang H., Vora D.K., Targan S.R., Toyoda H., Beaudet A.L., Rotter J.I. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology. 109:1995;440-448.
6. Braun C., Zahn R., Martin K., Albert E., Folwaczny C. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol. 101:2001;357-360.
7. McFarlane I.G. Autoimmune liver diseases. Scand J Clin Lab Invest Suppl. 235:2001;53-60.
8. Aadland E., Schrumpf E., Fausa O., Elgjo K., Heilo A., Aakhus T., et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol. 22:1987;655-664.
9. Bloom S., Fleming K., Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut. 36:1995;604-609.
10. Adams D.H., Hubscher S.G., Shaw J., Johnson G.D., Babbs C., Rothlein R., et al. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 14:1991;426-431.
11. Polzien F., Ramadori G. Increased intercellular adhesion molecule-1 serum concentration in cholestasis. J Hepatol. 25:1996;877-886.
12. Spurkland A., Saarinen S., Boberg K.M., Mitchell S., Broome U., Caballeria L., et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 53:1999;459-469.
13. Chapman R.W., Varghese Z., Gaul R., Patel G., Kokinon N., Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut. 24:1983;38-41.
14. Boberg K.M., Spurkland A., Rocca G., Egeland T., Saarinen S., Mitchell S., et al. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol. 36:2001;886-890.
15. Mitchell S.A., Grove J., Spurkland A., Boberg K.M., Fleming K.A., Day C.P., et al. Association of the tumor necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut. 49:2001;288-294.
16. Bernal W., Moloney M., Underhill J., Donaldson P.T. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol. 30:1999;237-241.
17. Satsangi J., Chapman R.W., Haldar N., Donaldson P., Mitchell S., Simmons J., et al. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology. 121:2001;124-130.
18. Cullen S., Jewell D., Chapman R. Susceptibility of primary sclerosing cholangitis is associated with a polymorphism of the MMP-9 (gelantinase B) gene. Gut. 50:2002;A30.
19. Donaldson P.T., Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol. 15:2001;611-627.
20. Li J.H., Yang X.S., Cullen S., Lin K.L., Armuzzi A., Ahmad T., et al. The intercellular adhesion molecule-1 polymorphisms in IBD. British Society of Gastroenterology Annual Meeting, 17-20 March. 2002;BMJ, Birmingham.
21. Welsh K., Bunce M. Molecular typing for the MHC with PCR-SSP. Rev Immunogenet. 1:1999;157-176.
22. Bunce M., O'Neill C.M., Barnardo M.C., Krausa P., Browning M.J., Morris P.J., et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 46:1995;355-367.
23. Boberg K.M., Spurkland A., Rocca G., Egeland T., Saarinen S., Mitchell S., et al. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol. 36:2001;886-890.
24. Farrant J.M., Doherty D.G., Donaldson P.T., Vaughan R.W., Hayllar K.M., Welsh K.I., et al. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology. 16:1992;390-395.
25. Olerup O., Olsson R., Hultcrantz R., Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 108:1995;870-878.
26. Mehal W.Z., Lo Y.M., Wordsworth B.P., Neuberger J.M., Hubscher S.C., Fleming K.A., et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 106:1994;160-167.
27. Miller J., Knorr R., Ferrone M., Houdei R., Carron C.P., Dustin M.L. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med. 182:1995;1231-1241.
28. Joling P., Boom S., Johnson J., Dekker M.E., van den Tweel J.G., Schuurman H.J., et al. Domain 5 of the intercellular adhesion molecule-1 (ICAM-1) is involved in adhesion of B-cells and follicular dendritic cells. Adv Exp Med Biol. 355:1994;131-135.
29. Reilly P.L., Woska J.R. Jr, Jeanfavre D.D., McNally E., Rothlein R., Bormann B.J. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol. 155:1995;529-532.